Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer with UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS)

Sandip M. Prasad, William C. Huang, Neal D. Shore, Brian Hu, Marc Bjurlin, Gordon Brown, Pencho Genov, Dimitar Shishkov, Alexandre Khuskivadze, Tosho Ganev, Dobri Marchev, Igor Orlov, Evgeny Kopyltsov, Vadim Zubarev, Alexander Nosov, Dmitrii Komlev, Brent Burger, Sunil Raju, Andrew Meads, Mark Schoenberg

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer with UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS)'. Together they form a unique fingerprint.

Medicine & Life Sciences